{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:08:16Z","timestamp":1787317696846,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T00:00:00Z","timestamp":1693353600000},"content-version":"am","delay-in-days":333,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006342","name":"Association Vaincre la Mucoviscidose","doi-asserted-by":"publisher","award":["RF20200502713\/1\/1\/57"],"award-info":[{"award-number":["RF20200502713\/1\/1\/57"]}],"id":[{"id":"10.13039\/501100006342","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jpba.2022.115011","type":"journal-article","created":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T11:41:04Z","timestamp":1660909264000},"page":"115011","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["A rapid and quantitative reversed-phase HPLC-DAD\/ELSD method for lipids involved in nanoparticle formulations"],"prefix":"10.1016","volume":"220","author":[{"given":"Yannick","family":"Mousli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Brachet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne Leblond","family":"Chain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludivine","family":"Ferey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2022.115011_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113851","article-title":"Liposome composition in drug delivery design, synthesis, characterization, and clinical application","volume":"176","author":"Large","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jpba.2022.115011_bib2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2020.06.022","article-title":"Recent advancements in liposome technology","volume":"156","author":"Filipczak","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jpba.2022.115011_bib3","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jpba.2022.115011_bib4","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41565-021-00898-0","article-title":"The current landscape of nucleic acid therapeutics","volume":"16","author":"Kulkarni","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jpba.2022.115011_bib5","unstructured":"U.S. Food, Drug Administration, Liposome Drug Products: Chemistry, Manufacturing, and Controls; Human Pharmacokinetics and Bioavailability; and Labeling Documentation, April 2018, \u3008https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/liposome-drug-products-chemistry-manufacturing-and-controls-human-pharmacokinetics-and\u3009 (accessed on March 2022)."},{"key":"10.1016\/j.jpba.2022.115011_bib6","unstructured":"European Medicines Agency, Reflection paper on the data requirements for intravenous liposomal products developed with reference to an innovator liposomal product, February 2013, \u3008https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/reflection-paper-data-requirements-intravenous-liposomal-products-developed-reference-innovator_en.pdf\u3009 (accessed on March 2022)."},{"key":"10.1016\/j.jpba.2022.115011_bib7","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/s41565-018-0246-4","article-title":"Minimum information reporting in bio\u2013nano experimental literature","volume":"13","author":"Faria","year":"2018","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jpba.2022.115011_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113642","article-title":"Analytical characterization of liposomes and other lipid nanoparticles for drug delivery","volume":"192","author":"Fan","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2022.115011_bib9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.chroma.2019.04.061","article-title":"Simultaneous separation of small interfering RNA and lipids using ion-pair reversed-phase liquid chromatography","volume":"1601","author":"Li","year":"2019","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2022.115011_bib10","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.jpba.2009.10.001","article-title":"Analysis of cationic liposomes by reversed-phase HPLC with evaporative light-scattering detection","volume":"51","author":"Zhong","year":"2010","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"3","key":"10.1016\/j.jpba.2022.115011_bib11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/pharmaceutics8030029","article-title":"Rapid quantification and validation of lipid concentrations within liposomes","volume":"8","author":"Roces","year":"2016","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jpba.2022.115011_bib12","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.chroma.2004.12.036","article-title":"A rapid isocratic high-performance liquid chromatography method for determination of cholesterol and 1,2-dioleoyl-sn-glycero-3-phosphocholine in liposome-based drug formulations","volume":"1073","author":"Singh","year":"2005","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2022.115011_bib13","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ijpharm.2015.11.014","article-title":"HPLC analysis as a tool for assessing targeted liposome composition","volume":"497","author":"Oswald","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jpba.2022.115011_bib14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jpba.2015.11.020","article-title":"A versatile, quantitative analytical method for pharmaceutical relevant lipids in drug delivery systems","volume":"119","author":"Jeschek","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2022.115011_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2020.121320","article-title":"Analytical profiling and stability evaluation of liposomal drug delivery systems: a rapid UHPLC-CAD-based approach for phospholipids in research and quality control","volume":"220","author":"Weber","year":"2020","journal-title":"Talanta"},{"key":"10.1016\/j.jpba.2022.115011_bib16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijpharm.2019.05.038","article-title":"Development and validation of a novel UPLC-ELSD method for the assessment of lipid composition of nanomedicine formulation","volume":"566","author":"Varache","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jpba.2022.115011_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.113967","article-title":"Development of HPLC-CAD stability indicating assay method for polyethylene glycol-conjugated phospholipid (DMPE-PEG2000) and identification of its degradation products","volume":"198","author":"Kurmi","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2022.115011_bib18","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jpba.2008.06.027","article-title":"Quantification of pegylated phospholipids decorating polymeric microcapsules of perfluorooctyl bromide by reverse phase HPLC with a charged aerosol detector","volume":"48","author":"D\u00edaz-L\u00f3pez","year":"2008","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2022.115011_bib19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jchromb.2014.01.011","article-title":"A versatile ultra-high performance LC-MS method for lipid profiling","volume":"951\u2013952","author":"Knittelfelder","year":"2014","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2022.115011_bib20","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1146\/annurev-biochem-060409-092612","article-title":"Applications of mass spectrometry to lipids and membranes","volume":"80","author":"Harkewicz","year":"2011","journal-title":"Annu. Rev. Biochem."},{"issue":"5","key":"10.1016\/j.jpba.2022.115011_bib21","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4155\/bio-2017-0279","article-title":"Cationic lipid bioanalysis: understanding distribution of lipid nanoparticles for delivery of RNA therapeutics","volume":"10","author":"Hawthorne","year":"2018","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2022.115011_bib22","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1021\/acs.analchem.7b04836","article-title":"Analytical challenges and recent advances in mass spectrometry based lipidomics","volume":"90","author":"Rustam","year":"2018","journal-title":"Anal. Chem."},{"issue":"29","key":"10.1016\/j.jpba.2022.115011_bib23","doi-asserted-by":"crossref","first-page":"7711","DOI":"10.1007\/s00216-018-1388-9","article-title":"Chromatographic study of nucleoside-lipids by RP-UHPLC-DAD\/CAD","volume":"410","author":"Ferey","year":"2018","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2022.115011_bib24","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0021-9673(91)85083-R","article-title":"Determination of phosphatidylcholine, phosphatidylglycerol and their lyso forms from liposome dispersions by high-performance liquid-chromatography using high-sensitivity refractive-index detection","volume":"585","author":"Grit","year":"1991","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.jpba.2022.115011_bib25","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.chroma.2007.09.008","article-title":"Comparison of universal detectors for high-temperature micro liquid chromatography","volume":"1170","author":"Hazotte","year":"2007","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2022.115011_bib26","article-title":"Survivin silencing improved the cytotoxicity of carboplatin and melphalan in Y79 and primary retinoblastoma cells","volume":"589","author":"Gibson","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jpba.2022.115011_bib27","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jconrel.2019.02.014","article-title":"Co-delivery of miR-181a and melphalan by lipid nanoparticles for treatment of seeded retinoblastoma","volume":"298","author":"Tabatabaei","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jpba.2022.115011_bib28","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1039\/C6NR06701H","article-title":"Cationic switchable lipids: pH-triggered molecular switch for siRNA delivery","volume":"9","author":"Viricel","year":"2017","journal-title":"Nanoscale"},{"key":"10.1016\/j.jpba.2022.115011_bib29","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.addr.2017.07.015","article-title":"Beyond PEGylation: alternative surface-modification of nanoparticles with mucus-inert biomaterials","volume":"124","author":"Khutoryanskiy","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jpba.2022.115011_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119536","article-title":"Recent advances and prospects in nano drug delivery systems using lipopolyoxazolines","volume":"585","author":"Simon","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.jpba.2022.115011_bib31","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1021\/acs.accounts.1c00544","article-title":"Chemistry of lipid nanoparticles for RNA delivery","volume":"55","author":"Eygeris","year":"2022","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.jpba.2022.115011_bib32","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/s42003-021-02441-2","article-title":"Ionization and structural properties of mRNA lipid nanoparticles influence expression in intramuscular and intravascular administration","volume":"4","author":"Carrasco","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.jpba.2022.115011_bib33","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0021-9673(99)00471-9","article-title":"Comparison of the responses of triacylglycerols with an evaporative visible light scattering detector used in conventional, micro and capillary liquid chromatography","volume":"848","author":"H\u00e9ron","year":"1999","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2022.115011_bib34","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0021-9673(01)93706-9","article-title":"Study of the qualitative and quantitative properties of the light-scattering detector","volume":"288","author":"Stolyhwo","year":"1984","journal-title":"J. Chromatogr. A"},{"issue":"8","key":"10.1016\/j.jpba.2022.115011_bib35","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0165-9936(97)00072-1","article-title":"The evaporative light scattering detector: some applications in pharmaceutical analysis","volume":"16","author":"Kohler","year":"1997","journal-title":"Trends Anal. Chem."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708522004320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708522004320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:25:09Z","timestamp":1760001909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708522004320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":35,"alternative-id":["S0731708522004320"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2022.115011","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A rapid and quantitative reversed-phase HPLC-DAD\/ELSD method for lipids involved in nanoparticle formulations","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2022.115011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115011"}}